Showing results (1111-1120 of 2,125) with videos related to
Sort By:
Pageof 213
Journal of Ovarian Research|June 10, 2020
Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinomaKyung Un Choi, Ahrong Kim, Jee Yeon Kim, et al.Journal of Ovarian Research|May 16, 2021
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancerLi-Yuan Feng, Yong-Zhi Huang, Wei Zhang, et al.Journal of Ovarian Research|August 7, 2021
Genetic determination of the ovarian reserve: a literature reviewAleksandra V Moiseeva, Varvara A Kudryavtseva, Vladimir N Nikolenko, et al.Journal of Ovarian Research|February 10, 2023
Effect of hysterectomy on ovarian function: a systematic review and meta-analysisYibao Huang, Meng Wu, Chuqing Wu, et al.Journal of Ovarian Research|November 9, 2016
Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?Ghanim Khatib, Cenk Soysal, Cihan Çetin, et al.Journal of Ovarian Research|November 19, 2016
SNAP23 promotes the malignant process of ovarian cancerQi Sun, Xing Huang, Quanli Zhang, et al.Journal of Ovarian Research|December 4, 2016
Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancerXia Xu, Fei Deng, Mengmeng Lv, et al.Journal of Ovarian Research|October 22, 2016
Used protocols for isolation and propagation of ovarian stem cells, different cells with different traitsHossein Yazdekhasti, Zahra Rajabi, Soraya Parvari, et al.Journal of Ovarian Research|October 12, 2016
Long-term treatment with testosterone alters ovary innervation in adult pigsBarbara Jana, Karolina A Meller, Michał Bulc, et al.Journal of Ovarian Research|September 29, 2016
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancerAurélie Pelissier, Aurélie Roulot, Béatrice Guéry, et al.Pageof 213